Document is current

Article History

Received: 27 August 2025

Accepted: 19 October 2025

First Online: 3 December 2025

Declarations

:

: Not applicable.

: Not applicable.

: P.M.V. has served in a consulting or advisory role for AbbVie, Ascentage Pharma, AstraZeneca, BMS, GSK, Johnson & Johnson, Kite, Pfizer, and Regeneron; and has received research funding from AbbVie, Johnson & Johnson, and Regeneron. S.K. has received research funding from Celgene, Johnson & Johnson, Millennium, Novartis, and Sanofi. S.Z.U. has served in a consulting/advisory role for AbbVie, Amgen, BMS/Celgene, Celgene, Genentech, Gilead Sciences, GSK, Johnson & Johnson, Karyopharm Therapeutics, Merck, and Takeda; and has received research funding from Amgen, Array BioPharma, BMS, Celgene, GSK, Merck, Pharmacyclics, Sanofi, Seattle Genetics, and SkylineDx. J.C.Y. has served in a consulting/advisory role for Bristol Myers Squibb, Johnson & Johnson, and Sanofi; and has received research funding from Celgene, Genmab, GlaxoSmithKline, MingSight, Novartis, Pfizer, and Regeneron. Y.C.C. has received research funding from Amgen, Karyopharm, and Takeda; and has received honoraria or served as a consultant/advisor to Amgen, GSK, Johnson & Johnson, Neopharm/Promedico, and Takeda. E.S. is employed by Johnson & Johnson and has stock/other ownership interests in Johnson & Johnson. R.L.C. is employed by Johnson & Johnson and has stock/other ownership interests in Johnson & Johnson. C.H. is employed by Johnson & Johnson and has stock/other ownership interests in Johnson & Johnson. R.G. was employed by Johnson & Johnson at the time of this analysis and has stock/other ownership interests in Johnson & Johnson. B.A. is employed by Johnson & Johnson and has stock/other ownership interests in Johnson & Johnson. J.Z. is employed by Johnson & Johnson and has stock/other ownership interests in Johnson & Johnson. E.C. is employed by Johnson & Johnson and has stock/other ownership interests in Johnson & Johnson. T.P. is employed by Johnson & Johnson and has stock/other ownership interests in Johnson & Johnson. M.-V.M. has served in a consulting/advisory role for AbbVie, Amgen, Celgene, GlaxoSmithKline, Johnson & Johnson, Pfizer, Regeneron, Roche-Genentech, and Takeda; and has received honoraria from Amgen, AbbVie, Celgene, GlaxoSmithKline, Genentech, Johnson & Johnson, Sanofi, and Takeda.